Expected individual benefit of prophylactic platelet transfusions in hemato‐oncology patients based on bleeding risks-Reference-Cited by-同舟云学术

Expected individual benefit of prophylactic platelet transfusions in hemato‐oncology patients based on bleeding risks

Published:2021-07-15 Issue:9 Volume:61 Page:2578-2587
ISSN:0041-1132
Container-title:Transfusion
language:en
Short-container-title:Transfusion

Author:

Cornelissen Loes L.¹²³^ORCID,Caram‐Deelder Camila¹³^ORCID,Fustolo‐Gunnink Susanna F.¹³⁴^ORCID,Groenwold Rolf H. H.³^ORCID,Stanworth Simon J.⁵⁶⁷⁸^ORCID,Zwaginga Jaap Jan¹²^ORCID,Bom Johanna G.¹³^ORCID

Affiliation:

1. Jon J van Rood Center for Clinical Transfusion Research, Sanquin/LUMC Leiden The Netherlands

2. Department of Hematology Leiden University medical Center Leiden The Netherlands

3. Department of Clinical Epidemiology Leiden University Medical Center Leiden The Netherlands

4. Department of Pediatric Hematology, Emma Children's Hospital, Amsterdam University Medical Center (UMC) University of Amsterdam Amsterdam The Netherlands

5. Transfusion Medicine, NHS Blood and Transplant (NHSBT) Oxford UK

6. Department of Haematology Oxford University Hospitals NHS Foundation Trust Oxford UK

7. Radcliffe Department of Medicine University of Oxford Oxford UK

8. NIHR Oxford Biomedical Research Centre Oxford UK

Funder

Research and Development

Publisher

Wiley

Subject

Hematology,Immunology,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/trf.16587